ID
33601
Beschrijving
Firebird 2 Versus Excel Sirolimus-eluting Stent in Treating Real-world Patients With Coronary Artery Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01373632
Link
https://clinicaltrials.gov/show/NCT01373632
Trefwoorden
Versies (1)
- 15-12-18 15-12-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
15 december 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Coronary Artery Disease NCT01373632
Eligibility Coronary Artery Disease NCT01373632
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Myocardial Infarction
Datatype
boolean
Alias
- UMLS CUI [1]
- C0027051
Beschrijving
Medical contraindication Placement of stent | Antiplatelet therapy Dual Unable
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C0522776
- UMLS CUI [2,1]
- C1096021
- UMLS CUI [2,2]
- C0205173
- UMLS CUI [2,3]
- C1299582
Beschrijving
Previous stent placement
Datatype
boolean
Alias
- UMLS CUI [1]
- C2114504
Beschrijving
Brand Coronary stent
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0592503
- UMLS CUI [1,2]
- C0687568
Beschrijving
Informed Consent Lacking
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C0332268
Similar models
Eligibility Coronary Artery Disease NCT01373632
- StudyEvent: Eligibility
C0032961 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0439165 (UMLS CUI [1,2])
C0205042 (UMLS CUI [2,1])
C0442016 (UMLS CUI [2,2])
C0205164 (UMLS CUI [2,3])
C1265611 (UMLS CUI [2,4])
C0332197 (UMLS CUI [1,2])
C0522776 (UMLS CUI [1,3])
C0522776 (UMLS CUI [1,2])
C1096021 (UMLS CUI [2,1])
C0205173 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
C0687568 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,2])